A Phase III Study of Re-Irradiation in Recurrent Glioblastoma
Stopped This study will not be proceeding due to lack of funding from anticipated sources
Conditions
Interventions
- DRUG: TMZ plus concurrent re-irradiation
- DRUG: Temozolomide
Sponsor
AHS Cancer Control Alberta